Prion-like Spreading of Disease in TDP-43 Proteinopathies

被引:1
|
作者
Pongracova, Emma [1 ]
Buratti, Emanuele [1 ]
Romano, Maurizio [2 ]
机构
[1] Int Ctr Genet Engn & Biotechnol, Padriciano 99, I-34149 Trieste, Italy
[2] Univ Trieste, Dept Life Sci, Via A Valerio 28, I-34127 Trieste, Italy
关键词
TDP-43; proteinopathy; prion-like; ALS; FTLD-TDP; pathological spreading; aggregation; cell-to-cell transmission; FRONTOTEMPORAL LOBAR DEGENERATION; DNA-BINDING PROTEIN; AMYOTROPHIC-LATERAL-SCLEROSIS; NUCLEAR FACTOR TDP-43; MESSENGER-RNA; STRUCTURAL DETERMINANTS; PHASE-SEPARATION; GENE-EXPRESSION; ALS; AGGREGATION;
D O I
10.3390/brainsci14111132
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
TDP-43 is a ubiquitous nuclear protein that plays a central role in neurodegenerative disorders collectively known as TDP-43 proteinopathies. Under physiological conditions, TDP-43 is primarily localized to the nucleus, but in its pathological form it aggregates in the cytoplasm, contributing to neuronal death. Given its association with numerous diseases, particularly ALS and FTLD, the mechanisms underlying TDP-43 aggregation and its impact on neuronal function have been extensively investigated. However, little is still known about the spreading of this pathology from cell to cell. Recent research has unveiled the possibility that TDP-43 may possess prion-like properties. Specifically, misfolded TDP-43 aggregates can act as templates inducing conformational changes in native TDP-43 molecules and propagating the misfolded state across neural networks. This review summarizes the mounting and most recent evidence from in vitro and in vivo studies supporting the prion-like hypothesis and its underlying mechanisms. The prion-like behavior of TDP-43 has significant implications for diagnostics and therapeutics. Importantly, emerging strategies such as small molecule inhibitors, immunotherapies, and gene therapies targeting TDP-43 propagation offer promising avenues for developing effective treatments. By elucidating the mechanisms of TDP-43 spreading, we therefore aim to pave the way for novel therapies for TDP-43-related neurodegenerative diseases.
引用
收藏
页数:28
相关论文
共 50 条
  • [31] TDP-43 proteinopathies: a new wave of neurodegenerative diseases
    de Boer, Eva Maria Johanna
    Orie, Viyanti K.
    Williams, Timothy
    Baker, Mark R.
    De Oliveira, Hugo M.
    Polvikoski, Tuomo
    Silsby, Matthew
    Menon, Parvathi
    van den Bos, Mehdi
    Halliday, Glenda M.
    van den Berg, Leonard H.
    Van den Bosch, Ludo
    van Damme, Philip
    Kiernan, Matthew
    van Es, Michael A.
    Vucic, Steve
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2021, 92 (01): : 86 - 95
  • [32] Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological Features of TDP-43 Proteinopathies
    Igaz, Lionel M.
    Kwong, Linda K.
    Chen-Plotkin, Alice
    Winton, Matthew J.
    Unger, Travis L.
    Xu, Yan
    Neumann, Manuela
    Trojanowski, John Q.
    Lee, Virginia M. -Y.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (13) : 8516 - 8524
  • [33] Oxidative stress induced by glutathione depletion reproduces pathological modifications of TDP-43 linked to TDP-43 proteinopathies
    Iguchi, Yohei
    Katsuno, Masahisa
    Takagi, Shinnosuke
    Ishigaki, Shinsuke
    Niwa, Jun-ichi
    Hasegawa, Masato
    Tanaka, Fumiaki
    Sobue, Gen
    NEUROBIOLOGY OF DISEASE, 2012, 45 (03) : 862 - 870
  • [34] O-GlcNAcylation of TDP-43 suppresses proteinopathies and promotes TDP-43's mRNA splicing activity
    Zhao, Meng-Jie
    Yao, Xiao
    Wei, Ping
    Zhao, Chen
    Cheng, Meng
    Zhang, Dong
    Xue, Wen
    He, Wen-Tian
    Xue, Weili
    Zuo, Xinxin
    Jiang, Lei-Lei
    Luo, Zhiyuan
    Song, Jiaqi
    Shu, Wen-Jie
    Yuan, Han-Ye
    Liang, Yi
    Sun, Hui
    Zhou, Yan
    Zhou, Yu
    Zheng, Ling
    Hu, Hong-Yu
    Wang, Jiwu
    Du, Hai-Ning
    EMBO REPORTS, 2021, 22 (06)
  • [35] Prion-like Spreading in Tauopathies
    Ayers, Jacob I.
    Giasson, Benoit I.
    Borchelt, David R.
    BIOLOGICAL PSYCHIATRY, 2018, 83 (04) : 337 - 346
  • [36] Cryptic exon inclusion in TDP-43 proteinopathies: opportunities and challenges
    Decker, Lorena
    Menge, Sonja
    Freischmidt, Axel
    NEURAL REGENERATION RESEARCH, 2025, 20 (07) : 2003 - 2004
  • [37] α-Synuclein emulsifies TDP-43 prion-like domain-RNA liquid droplets to promote heterotypic amyloid fibrils
    Dhakal, Shailendra
    Mondal, Malay
    Mirzazadeh, Azin
    Banerjee, Siddhartha
    Ghosh, Ayanjeet
    Rangachari, Vijayaraghavan
    COMMUNICATIONS BIOLOGY, 2023, 6 (01)
  • [38] Prion-like C-Terminal Domain of TDP-43 and α-Synuclein Interact Synergistically to Generate Neurotoxic Hybrid Fibrils
    Dhakal, Shailendra
    Wyant, Courtney E.
    George, Hannah E.
    Morgan, Sarah E.
    Rangachari, Vijayaraghavan
    JOURNAL OF MOLECULAR BIOLOGY, 2021, 433 (10)
  • [39] Prion-like nuclear aggregation of TDP-43 during heat shock is regulated by HSP40/70 chaperones
    Udan-Johns, Maria
    Bengoechea, Rocio
    Bell, Shaughn
    Shao, Jieya
    Diamond, Marc I.
    True, Heather L.
    Weihl, Conrad C.
    Baloh, Robert H.
    HUMAN MOLECULAR GENETICS, 2014, 23 (01) : 157 - 170
  • [40] Incidence and morphology of secondary TDP-43 proteinopathies: Part 2
    Acewicz, Albert
    Stepien, Tomasz
    Felczak, Paulina
    Tarka, Sylwia
    Wierzba-Bobrowicz, Teresa
    FOLIA NEUROPATHOLOGICA, 2023, 61 (02) : 111 - 120